Christopher P Shryock
First SEC filing: Dec. 17, 2025 · Latest: June 17, 2026
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 15, 2026 | MDLN | F | 872 | $36.61 | $31,924 | 11,031 Direct | -7.33% | Disposed | -2.2% (price as of 2026-10-05) |
| March 5, 2026 | MDLN | A | 11,903 | · | · | 11,903 Direct | · | Acquired | (price as of 2026-10-05) |
| Dec. 16, 2025 | MDLN | A | 40,638 | · | · | 40,638 Indirect | · | Acquired | (price as of 2026-10-05) |
| Dec. 16, 2025 | MDLN | A | 496,049 | · | · | 496,049 Indirect | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 16, 2025 | MDLN | Incentive Units of Medline Holdings, LP | Class A Common Stock | · | · | 40,638 | Acquired |
| Dec. 16, 2025 | MDLN | Incentive Units of Medline Holdings, LP | Class A Common Stock | · | · | 496,049 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.